This page was generated by AI. It is not a source of trustworthy medical information.
The curated page (written by a real person) is here
other ai pages: AVM | SCA | aica | brainstem | dissection | pica | strokes | subclavian | tia | treatment | vbi
An arteriovenous malformation, commonly abbreviated as AVM, is an abnormal tangle of blood vessels in which arteries connect directly to veins without an intervening capillary bed. This congenital vascular anomaly disrupts normal blood flow and can occur anywhere in the body, including the brain and the inner ear region. When an AVM develops near the auditory and vestibular pathways, it can produce a distinctive set of symptoms involving balance and hearing.
The inner ear and the vestibulocochlear nerve rely on a fragile and precisely regulated blood supply. An AVM in the posterior fossa, the angle between the brainstem and the cerebellum, or within the temporal bone can shunting blood away from normal tissue, creating a vascular steal phenomenon. This altered hemodynamics can lead to ischemia, venous congestion, or microhemorrhage, all of which can disrupt the cochlea and vestibular apparatus. Additionally, an AVM may exert direct compression on the vestibulocochlear nerve, producing audiovestibular symptoms.
Vertigo, the false sensation of spinning or movement, is one of the most common presenting symptoms when an AVM affects the vestibular system. Patients often describe sudden episodes of rotational vertigo, similar to Meniere's disease or vestibular migraine. Some individuals experience a persistent feeling of disequilibrium rather than true vertigo, especially when the AVM causes gradual brainstem compression.
Hearing symptoms can range from mild high-frequency loss to profound deafness. The hearing loss is typically sensorineural, meaning it arises from damage to the cochlea or the auditory nerve. In some cases, the hearing loss is sudden, mimicking sudden sensorineural hearing loss. In others, it progresses slowly over months or years, which can delay diagnosis.
Tinnitus, or ringing in the ear, is frequently reported by patients with an AVM near the auditory pathways. The tinnitus may be pulsatile, synchronous with the heartbeat, due to turbulent blood flow within the malformation. This pulsatile tinnitus often serves as an important clinical clue that a vascular lesion may be present.
Additional symptoms may include aural fullness, hyperacusis (increased sensitivity to sound), imbalance, and oscillopsia (the sensation that the visual world is bouncing). Some patients also report headaches, facial numbness, or double vision when the brainstem is involved.
Diagnosing an AVM requires a high index of suspicion, especially when a patient presents with atypical vertigo or unilateral hearing symptoms. Audiometry and vestibular testing, such as electronystagmography or video head impulse testing, can confirm the functional deficit but cannot identify the vascular cause. The gold standard for imaging is cerebral angiography, which delineates the feeding arteries and draining veins. Magnetic resonance imaging and magnetic resonance angiography are also essential for evaluating the relationship of the AVM to the vestibulocochlear nerve and the brainstem.
Surgical removal of the AVM may be curative, particularly for superficial lesions in the cerebellar hemisphere or the temporal bone. The goal is complete excision while preserving hearing and vestibular function whenever possible. The surgical approach depends on the location and size of the malformation.
Endovascular embolization involves threading a catheter into the blood vessels and injecting a glue-like substance or coils to occlude the abnormal vessels. This technique may be used as a standalone treatment for small AVMs or as an adjunct before surgery to reduce intraoperative bleeding.
Stereotactic radiosurgery delivers precisely focused radiation to the AVM, causing the vessel walls to thicken and gradually close over a period of one to three years. This option is preferred for deep or surgically inaccessible lesions. The treatment does not provide immediate symptom relief, and the risk of radiation injury to the cochlea or vestibular nerve must be considered.
Symptomatic treatment for vertigo may include vestibular suppressants, antihistamines, or antiemetics. In cases of sudden hearing loss, corticosteroids are sometimes prescribed, although their benefit in AVM-related hearing loss remains limited. Vestibular rehabilitation therapy can help patients compensate for chronic imbalance and improve their quality of life.
Recurrent vertigo, progressive or sudden hearing loss, and pulsatile tinnitus warrant a thorough evaluation by a clinician experienced in neurotology and vascular neurology. Because an AVM can hemorrhage, leading to life-threatening complications, early recognition and appropriate referral are critical. Any combination of audiovestibular symptoms with headache, focal neurological deficits, or seizures should prompt urgent neuroimaging.
The natural history of an AVM varies widely. Some lesions remain asymptomatic for life, while others cause progressive neurological decline or rupture. The annual hemorrhage risk is estimated at two to four percent, but this risk is higher after a prior bleed. With modern multimodal treatment, many patients achieve favorable outcomes, although hearing loss and vestibular deficits may persist despite successful eradication of the malformation. Long-term follow-up with serial imaging is necessary to monitor for recurrence or the development of new lesions.